BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4201308)

  • 1. Toxicology and pharmacology of the nitrosoureas.
    Oliverio VT
    Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308
    [No Abstract]   [Full Text] [Related]  

  • 2. CCNU (NSC-79037): preclinical toxicologic evaluation of a single intravenous infusion in dogs and monkeys.
    Schaeppi U; Fleischman RW; Phelan RS; Ethier MF; Luthra YK
    Cancer Chemother Rep 3; 1974 Sep; 5(1):53-64. PubMed ID: 4213020
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
    Wheeler GP; Alexander JA
    Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical toxicity of anticancer drugs and its prediction.
    Creaven PJ; Mihich E
    Semin Oncol; 1977 Jun; 4(2):147-63. PubMed ID: 406677
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicology of anticancer drugs.
    Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract]   [Full Text] [Related]  

  • 8. Formulation of three nitrosoureas for intravenous use.
    Davignon JP; Yang KW; Wood HB; Cradock JC
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract]   [Full Text] [Related]  

  • 9. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
    Gralla EJ; Coleman GL; Jonas AM
    Cancer Chemother Rep 3; 1974 Sep; 5(1):1-7. PubMed ID: 4213305
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicology studies with d-tetrandrine (NSC-77037), a plant alkaloid with vascular and lymphotoxic effects in dogs and monkeys.
    Gralla EJ; Coleman GL; Jonas AM
    Cancer Chemother Rep 3; 1974 Sep; 5(1):79-85. PubMed ID: 4213510
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
    Baril BB; Baril EF; Laszlo J; Wheeler GP
    Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
    Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacology of antineoplastic agents (second of two parts).
    Chabner BA; Myers CE; Coleman CN; Johns DG
    N Engl J Med; 1975 May; 292(22):1159-68. PubMed ID: 47611
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of the nitrosoureas: an overview.
    Oliverio VT
    Cancer Treat Rep; 1976 Jun; 60(6):703-7. PubMed ID: 821608
    [No Abstract]   [Full Text] [Related]  

  • 16. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB; Issell BF
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of mechanism of action studies of the nitrosoureas.
    Bono VH
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synthesis of antitumor nitrosourea derivatives and chemical studies of their mechanism of action].
    Kamiya S
    Eisei Shikenjo Hokoku; 1986; (104):1-19. PubMed ID: 3471287
    [No Abstract]   [Full Text] [Related]  

  • 19. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study on the influence of two 2-chloroethylnitrosoureas with different carbamoylating potential towards glutathione and glutathione-related enzymes in different organs of the rat.
    Stahl W; Eisenbrand G
    Free Radic Res Commun; 1991; 14(4):271-8. PubMed ID: 1874456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.